Purchase Order 36C25023P0906
Award Date 3/24/23
Potential Completion Date 3/23/24
Potential Value $237K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92130, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Travere Therapeutics, Inc. for the delivery of the pharmaceutical product Chenodal. The firm fixed price purchase order, valued at $189,200.00, has a completion date of September 30, 2022. Travere Therapeutics is a biopharmaceutical company that specializes in rare disease therapies and has received numerous federal contract awards from the VA and other agencies to supply...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Travere Therapeutics, Inc. to provide the drug CHENODAL 250MG (CHENODIOL) for $200,552 with a completion date of June 30, 2025. Travere Therapeutics is a biopharmaceutical company that specializes in rare disease therapies and has received prior federal contracts to supply pharmaceuticals like Thiola and Cholbam to the VA and other government agencies. This contract was awarded...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration to Travere Therapeutics, Inc., a biopharmaceutical company, for the supply of CHENODAL 250MG. The potential value of the award is $236,500.00, with a completion date of September 30, 2022. The contract is not associated with any set-aside program. Travere Therapeutics, Inc. is a for-profit organization and manufacturer of goods that has received numerous federal contract...
- This is a firm fixed price purchase order awarded to Travere Therapeutics, Inc., a biopharmaceutical company specializing in rare disease therapies, by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) for the supply of the pharmaceutical product CHENODAL 250 MG 6 DOSES. The contract, which has a potential value of $236,500.00, has a completion date of December 30, 2022. Travere Therapeutics holds a General Services Administration (GSA) Schedule contract for...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Travere Therapeutics, Inc., a biopharmaceutical company specializing in rare disease therapies. The $212,584.00 firm fixed-price purchase order is for the delivery of pharmaceutical drugs, with a period of performance ending on September 30, 2025. Travere Therapeutics holds a Federal Supply Schedule (FSS) contract with the VA as well as two Blanket Purchase Agreements (BPAs) specifically covering the procurement...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Travere Therapeutics, Inc., a biopharmaceutical company specializing in rare disease therapies. The contract, valued at $94,600.00, is for the delivery of the pharmaceutical product CHENDAL 250MG. The award is part of Travere's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs with the VA, and the company also holds a $25 million Blanket Purchase Agreement (BPA) with the VA...
- Travere Therapeutics, Inc. was awarded a $18,542.20 firm fixed price delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to supply Thioproin pharmaceutical products. The delivery order was issued under Travere's Pharmaceuticals and Drugs GSA Schedule contract (FSS-61-IB) for products to be delivered to the VA medical facility located in San Diego, California by June 2024. No set-aside designation was applied to this...
- Travere Therapeutics, Inc. was awarded a $11,280.58 firm fixed price delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The delivery order was issued under Travere's Pharmaceuticals and Drugs General Services Administration Federal Supply Schedule contract to supply FILSPARI to VA medical facilities located in San Diego, California. No set-aside designation was applied to this award. Travere Therapeutics holds several...
- This federal contract award to Travere Therapeutics, Inc. is for the delivery of the drug Thiola Tiopronin. The contract, valued at $11,125.32, is a firm fixed price delivery order issued against Travere's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the U.S. Department of Veterans Affairs (VA). The award, which does not have a set-aside designation, has an ultimate completion date of August 26, 2024. Travere Therapeutics is a biopharmaceutical company specializing...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price delivery order to Travere Therapeutics, Inc., a biopharmaceutical company, to provide the pharmaceutical drug FILSPARI 200 MG. The contract, valued at $11,280.64, was issued under Travere's Pharmaceuticals and Drugs GSA Schedule contract and will be used to supply VA medical facilities in support of healthcare services for veterans. The contract does not have a set-aside designation. Travere...